Intravitreal ranibizumab
One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
... Patients were divided into two treatment groups: a combined IVR + RF-PDT group and an IVR monotherapy group. Before August 2010, 30 eyes from 30 consecutive patients were treated with IVR alone and were placed in the IVR ...
7
Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab
... intravitreal ranibizumab. For the operation procedure, injection of 0.5 mg ranibizumab was performed at the lower pars plana with a sharp 27-gauge needle after complete sterile drap- ing and rinsing ...
5
Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration
... of intravitreal ranibizumab (Lucentis) treatment in patients with neovascular age-related macular degen- eration ...of intravitreal ranibizumab injections on central retinal thickness (CRT) of ...
9
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
... A 69-year-old female presented with vision reduction and metamorphopsia in her left eye for at least 3 weeks. Her baseline BCVA was 20/70. Fundus photography (Fig. 1a) showed the intraretinal hemorrhage with a white ...
7
Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study
... Fig. 2 a The relationship between the changes in the logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) 1 day after the first intravitreal ranibizumab (IVR) injection ...
5
Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
... monthly intravitreal ranibizumab injections and then were reviewed on a monthly basis and given further injections if needed based on the OCT-guided PrONTO trial (Prospective OCT Imaging of Patients with ...
6
Improving treatment provision of Wet AMD with intravitreal ranibizumab
... This quality improvement work was carried out in Manchester Royal Eye Hospital's macular treatment centre (MTC) where AMD patients have been assessed and treated with ranibizumab intravitreal injections ...
5
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
... A total of 70 eyes of 42 diabetic patients were included in this prospective randomized study. The study was approved by the ethical committee of the Mitghamr Lasik and Eye Center (approval number 212015), and all ...
5
Diabetic papillopathy treated with intravitreal ranibizumab
... after intravitreal ranibizumab injection, there was an increase in visual acuity in our ...vitreal ranibizumab could have helped the patient to ...
5
Simultaneous Intravitreal Ranibizumab and Dexamethasone Implant Administration at the Same Setting in Eyes with Severe Diabetic Macular Edema
... administer intravitreal ranibizumab and dexamethasone implant simulta- neously in eyes with severe DME in order to suppress both the VEGF and inflammatory cytokines at least at the initiation of ...
7
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
... Our study demonstrated that age is a significant factor that also affects the result of treatment with intravitreal ranibizumab in such eyes. According to our study, patients treated when they were 40 ...
5
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
... In this retrospective study, our results suggest that VA and CMT can be improved by intravitreal ranibizumab injection in BRVO patients with and without SRD. However, more marked improvement of macular ...
6
Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
... received intravitreal bevacizumab (IVB) injection, scatter photocoagulation, or grid laser photocoagulation for ...with intravitreal ranibizumab (IVR) injection and then switched to IVA because of ...
6
Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications
... diseases. Ranibizumab (Lucentis), the Fab fragment of recombinant humanized IgG1kmurine monoclonal antibody against VEGF-A, was approved for the treat- ment of ocular neovascular diseases such as wet age- related ...
7
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
... with intravitreal injections of ranibi- zumab (Lucentis; Novartis, Bülach, ...by intravitreal injec- tions of ranibizumab after the initial diagnosis, and (4) OCT examination before and after ...
8
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
... to ranibizumab, expressed as reso- lution of retinal fluid in eyes with PCV, was worse in eyes with than without hyperpermeability which is consistent with our results ...
8
Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion
... Fifty-four eyes of fifty-four consecutive patients with treatment-naïve CRVO were enrolled in this study. The aver- age patient age was 74 ± 11.81 years (range, 24–86 years). Twenty-eight patients (52%) were male, and ...
6
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
... receiving intravitreal injections of ranibizumab in the left eye for 2 years according to a Pro Re Nata treatment regimen for macular edema associated with branch retinal vein ...of intravitreal ...
7
Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
... to intravitreal ranibizumab ...to ranibizumab treatment, two cases received 2 and 4 intravitreal bevaci- zumab injections, respectively, while another one case was administered photodynamic ...
6
Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
... hemorrhage before treatment (Figure 3C–F), although best- corrected visual acuity in the left eye remained unchanged at 1/20 because of fibrotic macular degeneration. No recur- rence of choroidal ...
5